Kurniawan, J., A. D. Handayu, G. Aprilicia, D. R. Bahri, and I. Hasan. “Resistance-Associated Substitutions (RAS) and Clinical Factors As Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients”. Acta Medica Indonesiana, vol. 56, no. 4, Jan. 2025, p. 451, http://www.actamedindones.org/index.php/ijim/article/view/2625.